Ophthalmic Artery Chemosurgery for Less Advanced Intraocular Retinoblastoma: Five Year Review

Background Ophthalmic artery chemosurgery (OAC) for retinoblastoma was introduced by us 5 years ago for advanced intraocular retinoblastoma. Because the success was higher than with existing alternatives and systemic side effects limited we have now treated less advanced intraocular retinoblastoma (Reese-Ellsworth (RE) I-III and International Classification Retinoblastoma (ICRB) B and C). Methodology/Principal Findings Retrospective review of 5 year experience in eyes with Reese Ellsworth (Table 1) I (7 eyes), II (6 eyes) or III (6 eyes) and/or International Classification (Table 2) B (19 eyes) and C (11 eyes) treated with OAC (melphalan with or without topotecan) introduced directly into the ophthalmic artery. Patient survival was 100%. Ocular event-free survival was 100% for Reese-Ellsworth Groups I, II and III (and 96% for ICRB B and C) at a median of 16 months follow-up. One ICRB Group C (Reese-Ellsworth Vb) eye could not be treated on the second attempt for technical reasons and was therefore enucleated. No patient required a port and only one patient required transfusion of blood products. The electroretinogram (ERG) was unchanged or improved in 14/19 eyes. Conclusions/Significance Ophthalmic artery chemosurgery for retinoblastoma that was Reese-Ellsworth I, II and III (or International Classification B or C) was associated with high success (100% of treatable eyes were retained) and limited toxicity with results that equal or exceed conventional therapy with less toxicity.

• Publication year

  2012

• Venue

  PLoS ONE

• Publication date

  2012-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pone.0034120PMID 22545080PMCID 3335846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current Management Strategies for Intraocular Retinoblastoma

  2012cited by this paper
• Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.

  2011cited by this paper
• OCCURRENCE OF SECTORAL CHOROIDAL OCCLUSIVE VASCULOPATHY AND RETINAL ARTERIOLAR EMBOLIZATION AFTER SUPERSELECTIVE OPHTHALMIC ARTERY CHEMOTHERAPY FOR ADVANCED INTRAOCULAR RETINOBLASTOMA

  2011cited by this paper
• Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma

  2011cited by this paper
• Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.

  2011cited by this paper
• Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.

  2011cited by this paper
• Evaluation of ototoxicity in children treated for retinoblastoma: preliminary results of a systematic audiological evaluation

  2011cited by this paper
• Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.

  2010cited by this paper
• Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: ‘chemosurgery’The first Stallard lecture

  2010cited by this paper
• Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma.

  2010cited by this paper
• Preservation of fertility in patients with cancer.

  2009cited by this paper
• Preservation of fertility in patients with cancer.

  2009cited by this paper
• Preservation of fertility in patients with cancer [11]

  2009cited by this paper
• Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma

  2009cited by this paper
• Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma

  2009cited by this paper
• A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

  2008cited by this paper
• The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?

  2008cited by this paper
• Secondary Acute Myelogenous Leukemia in Patients with Retinoblastoma: Is Chemotherapy a Factor?

  2008cited by this paper
• Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?

  2007cited by this paper
• Evaluación de la ototoxicidad del cisplatino por el área bajo la curva audiométrica en retinoblastoma

  2006cited by this paper
• [Evaluation of cisplatin ototoxicity by the audiometric curve in retinoblastoma].

  2006cited by this paper
• Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.

  2004cited by this paper
• Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.

  2003cited by this paper
• Clinical result of prolonged primary chemotherapy in retinoblastoma patients.

  2003cited by this paper
• Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.

  2000cited by this paper
• 264 Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma (RB)

  1999cited by this paper
• External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines.

  1996cited by this paper
• Chemo-thermotherapy was successful in two cases of recurrence of intraocular retinoblastoma after irradiation

  1990cited by this paper
• Radiation therapy for retinoblastoma: comparison of results with lens-sparing versus lateral beam techniques.

  1987cited by this paper
• Treatment of bilateral groups I through III retinoblastoma with bilateral radiation.

  1981cited by this paper
• Visual results and ocular complications following radiotherapy for retinoblastoma.

  1978cited by this paper
• Radiation therapy in retinoblastoma. An analysis of 230 cases.

  1969cited by this paper
• The treatment of retinoblastoma by x-ray and triethylene melamine.

  1958influential reference

• Effect of intra-arterial chemotherapy drug regimens on globe salvage outcomes of retinoblastoma patients

  2025cites this paper
• Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors

  2025cites this paper
• Intra-arterial chemotherapy for retinoblastoma, outcomes analysis in 357 eyes: 13 years of experience in a referral center in Brazil.

  2025cites this paper
• Ruthenium-106 (106Ru) plaque brachytherapy as salvage treatment for retinoblastoma following intravenous chemotherapy.

  2024cites this paper
• Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial.

  2023cites this paper
• Ocular survival after intra‐arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution

  2022cites this paper
• Treatment of Retinoblastoma: What Is the Latest and What Is the Future

  2022cites this paper
• Primary laser therapy as monotherapy for discrete retinoblastoma

  2021cites this paper
• Applications of Iodine-125 Plaque Radiotherapy for Residual or Recurrent Retinoblastoma.

  2021cites this paper
• Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG)

  2021cites this paper
• Survival of retinoblastoma patients: a cohort study by two Russian medical centers

  2021cites this paper
• Intraocular Tumors

  2020cites this paper
• Pediatric Solid Tumors

  2020cites this paper
• Retinoblastoma management in 13q deletion syndrome patients using super‐selective chemotherapies and other cancer‐directed interventions

  2020cites this paper
• Intravenous Chemotherapy for Retinoblastoma in the Era of Intravitreal Chemotherapy: A Systematic Review

  2020cites this paper
• Ophthalmic artery chemosurgery for retinoblastoma: an initial 3-year experience from two major institutes in Egypt

  2020cites this paper
• Retinoblastoma: Diagnosis, Classification and Management

  2019cites this paper
• Ocular brachytherapy in the treatment of retinoblastoma. Experience in the Hospital Infantil de México

  2019cites this paper
• Changing Trends in Retinoblastoma Management and What Is in Store for the Future

  2019cites this paper
• Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity".

  2019cites this paper
• Re: Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide

  2018cites this paper
• Retrospective analysis of primarily treated group D retinoblastoma

  2018cites this paper
• Treatment Outcomes of Focal Laser Consolidation during Chemoreduction for Group B Retinoblastoma.

  2017cites this paper
• Molecular and Clinical Genetics of Retinoblastoma

  2017cites this paper
• Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma

  2017cites this paper
• Recent advances and challenges in the management of retinoblastoma

  2017cites this paper
• Intra-arterial and Intravitreal Chemotherapy for Retinoblastoma

  2017cites this paper
• Retinoblastoma: Imaging, Lasers, and Injections.

  2017cites this paper
• Intra-arterial Delivery of Chemotherapeutic Agents

  2016cites this paper
• Hemodynamic and Anatomic Variations Require an Adaptable Approach during Intra-Arterial Chemotherapy for Intraocular Retinoblastoma: Alternative Routes, Strategies, and Follow-Up

  2016cites this paper
• Favorable outcome of alternate systemic and intra-arterial chemotherapy for retinoblastoma

  2016cites this paper
• Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)

  2016cites this paper
• CHEMOTHERAPY IN RETINOBLASTOMA

  2016cites this paper
• Technique of Ophthalmic Artery Chemosurgery for Retinoblastoma

  2015cites this paper
• Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma.

  2015cites this paper
• Management of Retinoblastoma in Children: Current Status

  2015cites this paper
• Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy.

  2015cites this paper
• A retrospective analysis of severe intraoperative respiratory compliance changes during ophthalmic arterial chemosurgery for retinoblastoma

  2015cites this paper
• Retinoblastoma: Evidence for Stage-based Chemotherapy

  2015cites this paper
• Electroretinogram Monitoring of Retinoblastoma Treatment

  2015cites this paper
• Treatment of Retinoblastoma in 2015: Agreement and Disagreement.

  2015cites this paper
• Endovascular Management of Tumors of the Head, Neck, and Spine

  2015cites this paper
• Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review

  2014cites this paper
• Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

  2014cites this paper
• Intra‐arterial chemotherapy for retinoblastoma. Challenges of a prospective study

  2014cites this paper
• Retinoblastom Tedavisinde Güncel Yaklaşimlar Current Trends in the Management of Retinoblastoma

  2014cites this paper
• A descriptive study of the distribution and relative frequency of neonatal tumours at Chris Hani Baragwanath academic hospital from 1 January 1988 - 31 December 2012

  2014cites this paper
• Update on Ophthalmic Oncology 2012: Advances in Retinoblastoma and Uveal Melanoma

  2013cites this paper
• Impact of socioeconomic disparities on cause-specific survival of retinoblastoma.

  2013cites this paper
• Autonomic cardio‐respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma

  2013cites this paper
• Conservative treatment modalities in retinoblastoma

  2013cites this paper
• Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma

  2013cites this paper
• Advances in the genetics of eye diseases

  2013cites this paper
• Results of chemoreduction and focal consolidation therapy as a primary treatment modality of the remaining eye in bilateral retinoblastoma

  2013cites this paper
• Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution

  2013cites this paper
• Intra-arterial chemotherapy for retinoblastoma: a practical review

  2013cites this paper
• Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision

  2013cites this paper
• Establishment of the Relationship between Tumor Size and Range of Histological Involvement to Evaluate the Rationality of Current Retinoblastoma Management

  2013cites this paper
• Ophthalmic artery chemosurgery for retinoblastoma prevents new intraocular tumors.

  2013cites this paper
• Validating a nonhuman primate model of super-selective intraophthalmic artery chemotherapy: comparing ophthalmic artery diameters.

  2012cites this paper
• Retinoblastoma

  1992cites this paper